TCGA database also displayed that SHOX2 mRNA levels in the glioma patients with wild-type IDH were higher compared with patients of IDH-mut and 1p/19q non-codeletion or IDH-mut and 1p/19q codeletion (Fig. 1F). Here, SHOX2 is linked to central nervous system cancer.